Related Experiment Video
Updated: Aug 9, 2026

Assays for the Specific Growth Rate and Cell-binding Ability of Rotavirus
Published on: January 28, 2019
Insights
Rotavirus disease causes significant hospitalizations in European children under five. This review highlights the substantial burden, informing the need for rotavirus vaccines.
Area of Science:
- Pediatrics
- Infectious Diseases
- Public Health
Background:
- Rotaviruses are a leading cause of acute gastroenteritis hospitalizations in developed nations.
- The burden of rotavirus disease in children under five years old in Europe requires detailed examination.
Purpose of the Study:
- To review and quantify the burden of rotavirus disease in children under five years old within the European Union (EU-25).
- To provide data supporting the introduction of rotavirus vaccines in EU-25 countries.
Main Methods:
- This study is a review of existing data on rotavirus disease burden.
- Estimates of annual hospitalizations, incidence rates, and costs were compiled for the EU-25 population under five.
Main Results:
- An estimated 72,000-77,000 annual hospitalizations for community-acquired rotavirus disease occur in EU-25 children under five.
- Median hospitalization cost is Euro 1417 per case, with incidence rates varying from 0.3 to 11.9 per 1000 children.
- Hospital-acquired rotavirus disease accounts for a median of 21% of all rotavirus hospitalizations.
Conclusions:
- Rotavirus disease poses a significant health and economic burden on young children in Europe.
- Limited data exist on non-hospitalized cases, medical visits, and deaths, hindering a full impact assessment.
- Further epidemiological studies are crucial for evaluating the effectiveness of rotavirus vaccination programs in Europe.
Abstract:
Rotaviruses are a major cause of hospitalizations for acute gastroenteritis in developed countries. This review shows the burden of rotavirus disease in < 5-year-old children in Europe. An estimated 72,000-77,000 hospitalizations for community-acquired rotavirus disease occur annually in the 23 million under-fives living in the European Union (EU-25), with a median cost of Euro 1417 per case. Annual hospitalization incidence rates range from 0.3 to 11.9/1000 children < 5 years old (median 3/1000). The median proportion of hospital-acquired rotavirus disease among all cases of hospitalization for rotavirus disease is estimated to be 21%. Countries of the EU-25 require information on the burden of rotavirus disease to support introduction of rotavirus vaccines. Data on cases treated at home, medical visits, and emergency wards as well as rotavirus-associated deaths are limited. To fully evaluate the impact and effectiveness of rotavirus vaccination programmes in Europe, additional epidemiological studies will be critical and desirable.
Related Concept Videos
Respiratory Syncytial Virus Disease
Poliomyelitis
Bacterial Gastroenteritis
Cholera
Human Virome
Botulism
